KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Anti-von Willebrand Factor Nanobody, Caplacizumab (Synonym: Cablivi (TN))	2件: Caplacizumab (Synonym: Cablivi), Von Willebrand factor human	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
2	Anti-von Willebrand Factor Nanobody, INN = Caplacizumab (Synonym: Cablivi (TN))	2件: Caplacizumab (Synonym: Cablivi), Von Willebrand factor human	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
3	CABLIVI	1件: Caplacizumab (Synonym: Cablivi)	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
4	Cablivi®	1件: Caplacizumab (Synonym: Cablivi)	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
5	CAPLACIZUMAB (Synonym: Cablivi (TN))	1件: Caplacizumab (Synonym: Cablivi)	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
6	Caplacizumab (ALX-0081) (Synonym: Cablivi (TN))	1件: Caplacizumab (Synonym: Cablivi)	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
7	Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) (Synonym: Cablivi (TN))	2件: Caplacizumab (Synonym: Cablivi), Von Willebrand factor human	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64
8	Caplacizumab (an anti-von Willebrand Factor Nanobody) (Synonym: Cablivi (TN))	2件: Caplacizumab (Synonym: Cablivi), Von Willebrand factor human	1件: D11160 (Name: Cablivi (TN))	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬	1件: 64